Eli Lilly Challenges Novo Nordisk in Weight Loss Market

Name: Eli Lilly Challenges Novo Nordisk in Weight Loss Market
Uploaded: 2026-04-09T19:54:20Z
Duration: 30 s
Description: Following the launch of its oral weight loss pill Foundayo, Eli Lilly partners with telehealth companies like Amazon and Weight Watchers for distribution, with plans to expand to retail pharmacies. This move intensifies competition with Novo Nordisk's Wegovy, causing Novo Nordisk shares to decline.

The Claman Countdown · FBN · Apr 9, 2026 · 30s

Sign Up Now

Already a subscriber?

Following the launch of its oral weight loss pill Foundayo, Eli Lilly partners with telehealth companies like Amazon and Weight Watchers for distribution, with plans to expand to retail pharmacies. This move intensifies competition with Novo Nordisk's Wegovy, causing Novo Nordisk shares to decline.